ACET vs AKAM · rev $2.5M vs P/E 27, rev $2.17B
Adicet Bio Inc (ACET) versus Akamai Technologies Inc (AKAM) — a side-by-side from cached financials, not a winner call.
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Latest reported ACET revenue for 2026-06-30 was $2.5M. Net income was -$41.6M. Revenue was up 87.0% from 2026-03-31 to 2026-06-30. ACET currently screens at market cap $75.7M.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
ACET currently screens at market cap $75.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Not investment advice. Open the ACET and AKAM stock pages for the full models.
Not investment advice.